Company Profiles

driven by the PitchBook Platform

NanoVelos

NanoVelos
2013 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Angel LATEST DEAL TYPE
2 INVESTORS
Description

Operator of a cancer research company intended to develop a method of coating active substances with nano-particles of polysaccharides. The company's novel technology transforms generics to super-generics via a dextran-based nano-particle delivery system and exhibits dramatically improved tumor targeting, thereby enabling medical professionals in enhancing therapy efficacy while minimizing adverse effects on healthy tissues.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Delivery
Other Industries
Other Healthcare Services
Biotechnology
Primary Office
Rakowiecka 36
Warsaw, 02-532
Poland
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore NanoVelos’s full profile, request a free trial.

NanoVelos Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Angel (individual) 01-Jul-2015 Completed Startup
1. Early Stage VC 10-Apr-2013 Completed Startup
To view this company’s complete deal history including valuation and funding request access »

NanoVelos Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Giza Polish Ventures Venture Capital Minority 000 0000 000000 0
Michal Solowow Angel (individual) Minority 000 0000 000000 0

NanoVelos Executive Team (1)

Name Title Board
Seat
Contact
Info
Iwona Cymerman Ph.D Acting Chief Executive Officer & Board Member

NanoVelos Board Members (3)

Name Representing Role Since Contact
Info
Iwona Cymerman Ph.D NanoVelos Acting Chief Executive Officer & Board Member 000 0000
Marek Borzestowski Giza Polish Ventures President of Supervisory Board 000 0000
PaweĊ‚ Ciach NanoVelos Member of the Supervisory Board 000 0000